This article is freely available to all

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Over the past several years, the number of new anticonvulsantshas increased considerably. As the number of newagents increases, so too does the reporting of off-label uses inpsychiatric disorders. Interestingly enough, of all the anticonvulsantsavailable in the United States, only valproate is U.S.Food and Drug Administration (FDA) approved for use in acutemania.